Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCavendish Plc Regulatory News (CAV)

Share Price Information for Cavendish Plc (CAV)

Share Price is delayed by 15 minutes
Get Live Data
9.25    0.00 (0.00%)
Bid:
9.00
Ask:
9.50
Spread: 0.50 (5.556%)
Market Cap: £31.06m
CAV Live PriceLast checked at - London Stock Exchange

Intraday Cavendish Plc Share Chart

Directors Dealings

10 Apr 2026 15:18

RNS Number : 0537A
Cavendish PLC
10 April 2026
 

10 April 2026

 

Cavendish plc ("Cavendish")

 

Directors Dealings

 

Cavendish plc (AIM:CAV) operates a Deferred Bonus Scheme (the "DBS") and a Short Term Incentive Scheme (the "STIP") (together, the "Schemes") which are legacy schemes established by Cenkos Securities plc but under which outstanding awards at completion of the merger between finnCap Group plc and Cenkos Securities plc (on 7 September 2023) were rolled-over into awards over Cavendish shares.

 

On 8 April 2026, in accordance with the terms and conditions of the Schemes, one third of the DBS awards granted to certain employees, including Executive Directors, in 2023, and one-third of the STIP awards granted to certain employees, including Executive Directors, in July 2023, vested. The vested awards were satisfied by the transfer of shares allocated for that purpose under the Cenkos Securities Employee Benefit Trust (EBT).

 

Upon vesting of these awards, and after any off-market sales to the EBT to satisfy the income tax and NIC liability arising on the vesting, Julian Morse (Co-CEO) and Ben Procter (CFO) received and retained 681,423 and 235,578 shares respectively as shown in the table below. Julian Morse elected to satisfy the tax liability arising on vesting from his own funds and therefore retained the total number of vested shares.

 

Director /PDMR

Total of DBS and STIP Shares Vesting

Shares retained following any sale to cover tax liability

Resulting Shareholding

Shareholding % of ISC

Julian Morse, Co-CEO

681,432

681,423

7,921,190

2.05%

Ben Procter, CFO

444,487

235,578

1,832,113

0.47%

 

Further details of the vesting of awards and sale to cover tax liability are included in the notification below, made in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information, please contact:

 

CONTACTS

Cavendish (Management) Tel: +44 (0) 20 7220 0500

Julian Morse, Co-Chief Executive Officer investor.relations@cavendish.com

John Farrugia, Co-Chief Executive Officer

Ben Procter, Chief Financial Officer

 

SPARK Advisory Partners (Nominated Advisor)

Matt Davis Tel: +44 (0) 20 3368 3550

 

 

1

Details of the persons discharging managerial responsibility

a)

Name

Julian Morse

2

Reason for the notification

a)

Position/status

Co-CEO

b)

Initial notification/amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cavendish plc

b)

Legal Entity Identifier Code

213800DLRUJW6JVNS533

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 nominal value each

b)

Identification Code

GB00BGKPX309

c)

Nature of the transaction

Vesting of ordinary shares under the Short Term Incentive Plan awarded in 2023

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

 

Price(s) per share

Volume(s)

N/A

681,432

 

f)

Aggregated Information

- Price

- Volume

- Total Price

N/A

g)

Date of transaction

8 April 2026

h)

Place of transaction

Outside a trading venue

 

1

Details of the persons discharging managerial responsibility

a)

Name

Ben Procter

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cavendish plc

b)

Legal Entity Identifier Code

213800DLRUJW6JVNS533

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 nominal value each

b)

Identification Code

GB00BGKPX309

c)

Nature of the transaction

Vesting of ordinary shares under the Deferred Bonus Scheme and Short Term Incentive Plan awarded in 2023 and subsequent sale to satisfy the tax and NIC liabilities arising.

 

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

 

 

 

 

 

 

 

 

 

(1) Vesting of awards

Price(s) per share

Volume(s)

N/A

444,487

 

(2) Sale of shares to satisfy tax and NIC liabilities

Price(s) per share

Volume(s)

£0.0875

 

208,909

f)

Aggregated Information

- Price

- Volume

- Total Price

N/A

g)

Date of transaction

8 April 2026

h)

Place of transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBDQBKDPQD
12
Date   Source Headline
10th Apr 20263:18 pmRNSDirectors Dealings
1st Apr 20267:00 amRNSFull Year Trading Update
26th Feb 20263:38 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSDirectors Dealings
18th Dec 20259:08 amRNSDirectors Dealings
15th Dec 20254:15 pmRNSDirector Dealing: Correction
11th Dec 20254:00 pmRNSDirector Dealing
2nd Dec 20257:00 amRNSBlock Admission Return and Total Voting Rights
21st Nov 20254:45 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNS2026 Interim Results
16th Oct 202510:23 amRNSDirector Dealing
1st Oct 20257:00 amRNSHalf Year Trading Update: Profitable First Half
16th Sep 202511:00 amRNSResult of AGM
29th Aug 20257:00 amRNSTotal Voting Rights
18th Jul 202512:07 pmRNSPosting of Annual Report and Notice of AGM
8th Jul 20254:39 pmRNSHolding(s) in Company
3rd Jul 202511:13 amRNS-RInvestor Presentation via Investor Meet Company
26th Jun 20257:00 amRNS2025 Full Year Results
24th Jun 202510:32 amRNSResponse to press speculation
2nd Jun 20257:00 amRNSBlock Admission Return and Total Voting Rights
27th May 20259:02 amRNSHolding(s) in Company
1st May 20254:56 pmRNSTotal Voting Rights
1st May 20254:55 pmRNSDirectors Dealings
9th Apr 20254:02 pmRNSDirector Dealing
4th Apr 20257:00 amRNSFull Year Trading Update
4th Feb 202512:39 pmRNSCompany Name Change
31st Jan 202511:26 amRNSDirectors Dealings
31st Jan 202511:22 amRNSDirector Dealings
12th Dec 20242:56 pmRNSDirectors Dealings
2nd Dec 20247:00 amRNSBlock Admission Return and Total Voting Rights
13th Nov 20243:00 pmRNSDirectors Dealings
11th Nov 20247:00 amRNS2025 Interim Results
21st Oct 20242:37 pmRNSDirectors Dealings
7th Oct 20247:00 amRNSHalf Year Trading Update: Profitable First Half
24th Sep 20249:20 amRNSIntended Purchases of Shares by EBT
16th Sep 202412:42 pmRNSResult of AGM
16th Sep 20249:09 amRNSAGM Trading Statement
6th Sep 20247:00 amRNSRule 19.6(c) Confirmation
15th Aug 20243:00 pmRNSDirectors Dealings
1st Aug 20248:44 amRNSPosting of Annual Report and Notice of AGM
26th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20244:33 pmRNSDirector Dealings
15th Jul 20247:00 amRNS2024 Full Year Results
12th Jun 20242:41 pmRNSHolding(s) in Company
24th May 20247:00 amRNSDirectorate Change
22nd Apr 202410:00 amRNSDirectors Dealings
8th Apr 20247:01 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSChange of Nominated Adviser
4th Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.